[Click e-Stock] "MetaLabs Holds Investment Properties Worth 3 Times Its Market Cap... Physical AI Venture Draws Attention"

An analysis has suggested that MetaLabs is increasing the potential for a revaluation of its corporate value, supported by improved financial performance, the value of its real estate holdings, and a new physical artificial intelligence (AI) business. Its investment property holdings are worth about 3.1 times its current market capitalization, and its move into hair transplant robots is also seen as a new growth driver.

MetaLabs focuses on licensing and distribution for fashion brands and is expanding into hair-loss healthcare and pharmaceutical distribution. As of the first half of 2026, its revenue breakdown was 64% from apparel, 15% from services, 12% from pharmaceuticals, and 9% from medical and other businesses.

Its financial performance is also improving. MetaLabs reported preliminary cumulative revenue of 98.7 billion won for the first three quarters of 2026, up 96.6% from the same period a year earlier. It posted an operating profit of 2.5 billion won, turning profitable.

Jihu, a researcher at ValueFinder, explained, "Revenue in the fashion business division rose 129% as licensing and distribution of premium brands expanded through major shopping channels, including Lotte Home Shopping, GS SHOP, and KT Alpha Shopping. Improved profitability at subsidiary Momolabs also contributed positively to the results."

The expansion of its consolidated subsidiaries also contributed to revenue growth. Revenue increased after Techlabs, followed by JK Medi, was included in the consolidated financial statements. Researcher Jihu forecast that growth would continue, driven by expansion in the core business and improved results at subsidiaries.

AI hair transplant robots are drawing attention as a new business. MetaLabs has signed a business agreement with Chinese medical robotics company Fengche Robotics to pursue joint research, regulatory approvals, and commercialization of AI hair transplant robots in Korea and overseas. The target for commercialization is Hairo, an AI hair transplant robot that has received Class III medical device approval from China's National Medical Products Administration (NMPA).

MetaLabs plans to use the medical device distribution infrastructure of its subsidiary MetaCare to introduce the robot to the domestic market, and to establish a robot-based hair transplant clinic operating model through Momolabs. Researcher Jihu viewed this as an opportunity to expand the company's existing hair-loss healthcare business into physical AI.

The value of its real estate holdings is another investment point. Based on company materials, ValueFinder estimated that MetaLabs' investment property holdings totaled more than 80 billion won as of the third quarter. This was about 3.1 times its market capitalization of 25.9 billion won at the time.

Researcher Jihu said, "The fact that the value of the company's real estate holdings alone substantially exceeds its market capitalization, together with its return to operating profitability, makes the shares sufficiently attractive as an undervalued asset. We expect benefits from rental income and rising property prices, and there is also room for further asset growth if market prices exceed book value." Jihu added, "The potential value of the company's real estate holdings is coming into focus alongside improved performance in its core business, raising expectations for a revaluation of its corporate value."

This content was produced with the assistance of AI translation services.